Oral ingestion of a hydrolyzed gelatin meal in subjects with normal weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and insulin

被引：0
作者：
Rubio I.G.S. [1 ]
Castro G. [1 ]
Zanini A.C. [1 ]
Medeiros-Neto G. [1 ,2 ]
机构：
[1] Department of Internal Medicine and Thyroid Unit (Lim-25), University of São Paulo Medical School, São Paulo
[2] Laboratório de Investigações Médicas (LIM-25), Faculdade de Medicina, Universidade de São Paulo, 01246-903, São Paulo, Av. Dr Arnaldo 455
来源：
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity | 2008年 / 13卷 / 1期
关键词：
Gelatin; Ghrelin; GLP-1; Glucose; Insulin; Obesity; PYY;
D O I：
10.1007/BF03327784
中图分类号：
学科分类号：
摘要：
Gut hormones [ghrelin, peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)] are an important group of hormones that target appetite control. They are released from endocrine L cells of the small bowel in proportion to the volume, components and calories in a meal. In the current study, 20 g of gelatin (flavored and sweetened) were given to obese patients (n=12) and lean subjects (n=10). Subsequently, plasma samples were collected at-30-minute intervals up to 180 minutes and glucose, insulin, PYY, GLP-1 and ghrelin were assayed using specific and sensitive immunofluorometric and radioimmunoassays. As expected, obese patients had normal serum glucose levels, higher serum insulin, and lower plasma concentration of ghrelin at all times compared to lean subjects. GLP-1 plasma levels were significantly elevated at 60 minutes, peaking at 120 minutes in obese patients and lean subjects. As a consequence, there was a significant rise in serum insulin levels with a significantly higher peak level at 60 min (obese) and 30 min (lean). There were no significant changes in PYY plasma concentrations and no correlation was found between body mass index and concentrations of ghrelin, PYY and GLP-1 in the group of obese patients. In conclusion, a single gelatin meal induces a rise in plasma GLP-1 followed by an increase in serum levels of insulin. These findings may be applied to maximize satiety in obese patients as a means of improving adherence to calorie-controlled diets as well as provide better control of diabetic patients. ©2008, Editrice Kurtis.
引用
收藏
页码：48 / 53
页数：5
相关论文
共 18 条
[1]  
Zimmet P., Alberti K.G., Shaw J., Global and societal implications of the diabetes epidemic, Nature, 414, pp. 782-787, (2001)
[2]  
Bray G.A., Risks of obesity, Endocrinol. Metab. Clin. North Am, 32, pp. 787-804, (2003)
[3]  
Huda M.S.B., Wilding J.P.H., Pinkney J.H., Gut peptides and the regulation of appetite, Obes. Rev, 7, pp. 163-182, (2006)
[4]  
Korner J., Leibel R.L., To eat or not to eat - how the gut talks to the brain, N. Engl. J. Med, 349, pp. 926-928, (2003)
[5]  
Murphy K.G., Dhillo W.S., Bloom S.R., Gut peptides in the regulation of food intake and energy homeostasis, Endocr. Rev, 27, pp. 719-727, (2006)
[6]  
Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., Ghatei M.A., Bloom S.R., Inhibition of food intake in obese subjects by peptide YY3-36, N. Engl. J. Med, 349, pp. 941-948, (2003)
[7]  
Neary N.M., Small C.J., Druce M.R., Park A.J., Ellis S.M., Senijonous N.M., Dakin C.L., Filipsson K., Wang F., Kent A.S., Frost G.S., Ghatei M.A., Bloom S.R., Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively, Endocrinology, 146, pp. 5120-5127, (2005)
[8]  
Verdich C., Flint A., Gutzwiller J.P., Noslund E., Beglinger C., Hellstrom P.M., Long S.J., Morjan L.M., Holst J.J., Astrup A., A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans, J. Clin. Endocrinol. Metab, 86, pp. 4382-4389, (2001)
[9]  
Latner J.D., Schwartz M., The effects of a high-carbohydrate, high-protein or balanced lunch upon later food intake and hunger ratings, Appetite, 33, pp. 119-128, (1999)
[10]  
Bowen J., Noakes M., Clifton P.M., Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake, J. Clin. Endocrinol. Metab, 91, pp. 2913-2919, (2006)
12